Display options
Cite
Van Gool SW, Makalowski J, Bonner ER, et al. Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience. Medicines (Basel). 2020;7(5)doi: 10.3390/medicines7050029.
Van Gool, S. W., Makalowski, J., Bonner, E. R., Feyen, O., Domogalla, M. P., Prix, L., Schirrmacher, V., Nazarian, J., & Stuecker, W. (2020). Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience. Medicines (Basel, Switzerland), 7(5), . https://doi.org/10.3390/medicines7050029
Van Gool, Stefaan W, et al. "Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience." Medicines (Basel, Switzerland) vol. 7,5 (2020). doi: https://doi.org/10.3390/medicines7050029
Van Gool SW, Makalowski J, Bonner ER, Feyen O, Domogalla MP, Prix L, Schirrmacher V, Nazarian J, Stuecker W. Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience. Medicines (Basel). 2020 May 19;7(5). doi: 10.3390/medicines7050029. PMID: 32438648; PMCID: PMC7281768.
Copy Download .nbib Format: NLM
Share it on

Medicines (Basel). 2020 May 19;7(5). doi: 10.3390/medicines7050029.

Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience.

Medicines (Basel, Switzerland)

Stefaan W Van Gool, Jennifer Makalowski, Erin R Bonner, Oliver Feyen, Matthias P Domogalla, Lothar Prix, Volker Schirrmacher, Javad Nazarian, Wilfried Stuecker

Affiliations

  1. Immun-Onkologisches Zentrum Köln, Hohenstaufenring 30-32, 50674 Köln, Germany.
  2. Center for Genetic Medicine, Children's National Health System, Washington, DC 20010, USA.
  3. Institute for Biomedical Sciences, The George Washington University School of Medicine and health Sciences, Washington, DC 20052, USA.
  4. Zyagnum, Reißstrasse 1, 64319 Pfungstadt, Germany.
  5. Biofocus, Berghäuser Strasse 295, 45659 Recklinghausen, Germany.
  6. DIPG Research Institute, Universitäts-Kinderspital Zürich, Steinwiesstrasse 75, Ch-8032 Zürich,Switzerland.

PMID: 32438648 PMCID: PMC7281768 DOI: 10.3390/medicines7050029

[No abstract available.]

Keywords: DC vaccination; DIPG; Newcastle disease virus; PanTum Detect test; Th1 shift; hyperthermia; multimodal immunotherapy

References

  1. J Neurooncol. 2017 Apr;132(2):255-266 - PubMed
  2. Future Oncol. 2012 Oct;8(10):1349-59 - PubMed
  3. Eur J Cancer. 2017 Mar;73:38-47 - PubMed
  4. Lancet Oncol. 2006 Mar;7(3):241-8 - PubMed
  5. J Neurooncol. 2017 Oct;135(1):13-20 - PubMed
  6. Front Immunol. 2016 Jan 14;6:663 - PubMed
  7. Biomol Eng. 2001 Mar;17(3):95-111 - PubMed
  8. Acta Neuropathol. 2015 Dec;130(6):815-27 - PubMed
  9. Acta Neuropathol. 2016 Jun;131(6):803-20 - PubMed
  10. Int J Mol Sci. 2017 Apr 20;18(4): - PubMed
  11. Neuro Oncol. 2017 Aug 1;19(8):1025-1034 - PubMed
  12. Cancer Treat Rev. 2012 Feb;38(1):27-35 - PubMed
  13. NPJ Precis Oncol. 2018 Dec 17;2:29 - PubMed
  14. Oral Maxillofac Surg. 2016 Sep;20(3):295-302 - PubMed
  15. Oncotarget. 2018 Apr 10;9(27):19065-19078 - PubMed
  16. J Neurosurg Pediatr. 2018 Sep;22(3):288-296 - PubMed
  17. Cancer. 2010 Feb 1;116(3):705-12 - PubMed
  18. J Exp Med. 2018 Jan 2;215(1):141-157 - PubMed
  19. Lancet Oncol. 2018 Aug;19(8):1040-1050 - PubMed
  20. J Neurooncol. 2017 Aug;134(1):231-240 - PubMed
  21. BJU Int. 2015 Sep;116(3):321-9 - PubMed
  22. Virology. 2018 Dec;525:19-31 - PubMed
  23. Neuro Oncol. 2018 Jan 10;20(1):123-131 - PubMed
  24. Nat Commun. 2016 Apr 06;7:11185 - PubMed
  25. Expert Rev Anticancer Ther. 2015 Feb;15(2):157-64 - PubMed
  26. Am J Pathol. 2000 Jan;156(1):57-63 - PubMed
  27. J Vis Exp. 2019 Jun 8;(148): - PubMed
  28. Adv Cancer Res. 2014;121:235-259 - PubMed
  29. Int J Cancer. 2015 Mar 1;136(5):E313-25 - PubMed
  30. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Mar;121(3):301-6 - PubMed
  31. Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2716-36 - PubMed
  32. Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88 - PubMed
  33. Nat Commun. 2019 May 28;10(1):2235 - PubMed
  34. Eur J Cancer. 2019 Jun;114:27-35 - PubMed
  35. J Neurosurg. 2007 Jul;107(1 Suppl):1-4 - PubMed
  36. Clin Cancer Res. 2018 Dec 1;24(23):5850-5859 - PubMed
  37. J Neurooncol. 2017 Jan;131(1):1-9 - PubMed
  38. Neuro Oncol. 2015 Jan;17(1):160-6 - PubMed
  39. Oncoimmunology. 2017 May 12;6(7):e1328340 - PubMed
  40. J Clin Neurosci. 2018 Jan;47:285-293 - PubMed
  41. Radiother Oncol. 1999 Feb;50(2):199-204 - PubMed
  42. J Neurooncol. 2019 Oct;145(1):177-184 - PubMed
  43. J Neurosurg Pediatr. 2013 Mar;11(3):289-95 - PubMed
  44. J Clin Neurosci. 2019 Mar;61:5-9 - PubMed
  45. Front Oncol. 2012 Dec 28;2:205 - PubMed
  46. BMC Cancer. 2013 Dec 04;13:569 - PubMed
  47. PLoS One. 2019 Jun 19;14(6):e0217894 - PubMed
  48. Acta Neuropathol. 2012 Sep;124(3):439-47 - PubMed
  49. Exp Mol Pathol. 2018 Oct;105(2):166-174 - PubMed
  50. Childs Nerv Syst. 2020 Jan;36(1):39-46 - PubMed
  51. Sci Adv. 2018 Mar 07;4(3):eaar2766 - PubMed
  52. J Cancer. 2018 Jan 1;9(1):41-53 - PubMed
  53. Childs Nerv Syst. 2015 Oct;31(10):1773-80 - PubMed
  54. Mol Ther. 2018 Apr 4;26(4):1008-1019 - PubMed
  55. Clin Oral Investig. 2016 Mar;20(2):329-38 - PubMed
  56. Front Oncol. 2018 Apr 26;8:127 - PubMed
  57. Acta Neuropathol Commun. 2019 Apr 29;7(1):64 - PubMed
  58. Integr Cancer Ther. 2019 Jan-Dec;18:1534735418812691 - PubMed
  59. Neuro Oncol. 2019 Jan 1;21(1):83-94 - PubMed

Publication Types